Home Contact Us Health Care Professionals

safety

dosing

Case Studies

Resources  
   
       
   

Patient History                                                                           

39-year-old female with stage III breast cancer requiring neoadjuvant chemotherapy. Treatment regimen included:

bullet Dose-dense doxorubicin and cyclophosphamide (AC) for 4 cycles
bullet Paclitaxel for 4 cycles following AC.

Clinical Plan                                                                                 

Patient was very motivated to have a successful treatment course without any dose delays or dose reductions. She was diligent in maintaining her oral hygiene to reduce the risk of mucositis.

bullet To maintain oral health, she:

         - Underwent a full dental examination, cleaning, and
           fluoride administration prior to initiation of
           chemotherapy
         - Used antibacterial mouthwash and toothpaste, as well
           as baking soda/salt water rinses prior to     
           chemotherapy administration
         - Used GELCLAIR (bioadherent oral gel) multiple times
           daily before and after chemotherapy administration
           until her blood counts returned to normal.

Outcomes                                                                                    

bullet Patient continued her oral hygiene regimen throughout her treatment course, which she completed with no dose delays or dose reductions.
bullet With the use of GELCLAIR, patient experienced no mouth sores or dysphagia during treatment.

   
     

About Oral Mucositis - Steps to Relief - Treatment With GELCLAIR - Resources
Home - Contact Us - Health Care Professionals - Package Insert - References - Privacy Policy - EKRTX.com


© 2010 EKR Therapeutics, Inc. All rights reserved.
Marketed and distributed by: EKR Therapeutics, Inc., Bedminster, NJ 07921 under license of Helsinn Healthcare SA, Lugano, Switzerland
GELCLAIR® is a registered trademark of Helsinn Healthcare SA, Lugano, Switzerland